Pharmaceutical-business-review - clinicaltrials.pharmaceutical-business-review.com - PBR - Clinical Trials News
General Information:
Latest News:
Alcobra begins enrollment in comparative study of MG01CI 27 Aug 2013 | 04:05 pm
Biopharmaceutical company Alcobra has enrolled first patient in comparative study of MG01CI to compare varied doses in improving executive function benefits in patients with predominantly inattentive ...
Sanofi Pasteur begins Phase III study of Clostridium difficile vaccine in Canada 27 Aug 2013 | 11:00 am
Sanofi Pasteur, a vaccine division, has commenced Phase III clinical program, called Cdiffense, of investigational vaccine in Canada to prevent Clostridium difficile.
Takeda- Zinfandel commence Phase III trial of pioglitazone 27 Aug 2013 | 10:55 am
Takeda Pharmaceutical Company and its partner Zinfandel Pharmaceuticals have commenced Phase III trial, referred to as TOMMORROW, of investigational low dose pioglitazone (designated AD-4833 for the u...
GSK Phase III study of vercirnon fails to meet primary endpoint 26 Aug 2013 | 11:49 am
GlaxoSmithKline (GSK) has announced that its Phase III study of vercirnon, the SHIELD-1 study, in patients with moderate-to-severe Crohn's disease failed to meet its primary endpoint.
Catabasis commences Phase II CAT-2003 trial for hypertriglyceridemia, hypercholesterolemia 23 Aug 2013 | 03:19 pm
Clinical-stage company Catabasis Pharmaceuticals has commenced PATHWAYS I, Phase II trial of CAT-2003 in patients with hypertriglyceridemia and hypercholesterolemia.
Nymox reports positive results from Phase III trial of benign prostatic hyperplasia drug 23 Aug 2013 | 12:39 pm
Nymox Pharmaceutical has announced positive results from safety monitoring committee review of Phase III trial of investigational drug for benign prostatic hyperplasia (BPH), NX02-0018.
Cellular Biomedicine completes enrollment for Phase I hepatocellular carcinoma trial 23 Aug 2013 | 10:58 am
Cellular Biomedicine has completed patient enrollment for Phase I trial of tumor stem cell specific dendritic cell (TC-DC) therapy for hepatocellular carcinoma (HCC), a type of liver cancer.
Arno Therapeutics commences pharmacokinetic study of onapristone 22 Aug 2013 | 04:46 pm
Arno Therapeutics has commenced a pharmacokinetic (PK) study of onapristone followed by submission and approval of an Investigational Medicinal Product Dossier (IMPD) by the French Health Authority, L...
Oramed recruits patients to study orally ingestible insulin capsule 22 Aug 2013 | 01:22 pm
Oramed Pharmaceuticals has started recruiting patients for a new clinical trial of ORMD-0801, an orally ingestible insulin capsule, for patients with type 1 diabetes mellitus (T1DM) in Israel.
DiaMedica completes enrollment in DM199 single ascending dose diabetes study 21 Aug 2013 | 03:06 pm
Clinical stage biopharmaceutical company DiaMedica has completed enrollment of type 2 diabetic patients in the DM199 single ascending dose (SAD) clinical study.
